Published in HPB (Oxford) on January 29, 2016
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg (2000) 5.79
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med (2000) 4.92
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg (2005) 3.04
Obesity and cancer. Oncogene (2004) 3.01
Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg (2010) 1.85
Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases. Br J Surg (2013) 1.62
Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48
Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg (2007) 1.42
High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am J Pathol (2009) 1.25
Fatty liver: how frequent is it and why? Ann Hepatol (2004) 1.24
Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg (2007) 1.19
The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography. Arch Surg (2010) 1.05
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. Eur J Cancer (2011) 1.04
Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg (2010) 1.01
Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Ann Surg (2013) 0.97
Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. Hepatology (2012) 0.92
Ageing and hepatic steatosis exacerbate ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Ann Surg Oncol (2008) 0.90
Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases. Eur J Surg Oncol (2009) 0.86
Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases. J Gastrointest Surg (2011) 0.86
Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases. Surgery (2013) 0.86
Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges? World J Hepatol (2014) 0.82
The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy. HPB (Oxford) (2012) 0.81
Fatty liver suppressed the angiogenesis in liver metastatic lesions. Hepatogastroenterology (2001) 0.81
Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy. Eur J Surg Oncol (2014) 0.78
Metabolic syndrome and hepatic resection: improving outcome. HPB (Oxford) (2011) 0.78